Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Medchemexpress LLC Pasireotide acetate | 396091-76-2 | 99.5% | 1107.26 | 5 MG
Supplier: Medchemexpress LLC HY16381A5MG
Pasireotide acetate, also known as SOM230 acetate, is a long-acting cyclohexapeptide somatostatin analogue. It exhibits improved agonist activity across multiple somatostatin receptor subtypes (sst1, sst2, sst3, and sst5) and has demonstrated the ability to suppress the secretion of growth hormone (GH), insulin-like growth factor-I (IGF-I), and adrenocorticotropic hormone (ACTH), suggesting its potential effectiveness in managing conditions like acromegaly and Cushing's disease. Additionally, it possesses antisecretory, antiproliferative, and proapoptotic activities.
- Improved agonist activity at somatostatin receptors (sst1/2/3/5)
- Suppresses GH, IGF-I, and ACTH secretion
- Potential efficacy in acromegaly and Cushing's disease
- Exhibits antisecretory activity
- Exhibits antiproliferative activity
- Exhibits proapoptotic activity
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?